Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Phase 1/1b Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Conditions
Interventions
JANX008
Locations
18
United States
City of Hope Medical Center
Duarte, California, United States
University of California, Davis Comprehensive Cancer Center
Sacramento, California, United States
University of California San Diego Moores Cancer Center
San Diego, California, United States
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
University of Chicago Medical Center
Chicago, Illinois, United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
April 19, 2023
Primary Completion Date
January 1, 2026
Completion Date
October 1, 2027
Last Updated
October 14, 2025
NCT07227402
NCT06043817
NCT07144280
NCT05969860
NCT07431827
NCT06758401
Lead Sponsor
Janux Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions